DDR2 ameliorates nonalcoholic hepatic steatosis by activating the AMPK/ACC pathway
Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD), also termed non-alcoholic fatty liver disease (NAFLD), represents the predominant chronic hepatic condition globally, yet remains without successful drug-based interventions. Understanding the molecular mechanisms driving MAS...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Nature Portfolio
2026-03-01
|
| Ráidu: | Scientific Reports |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1038/s41598-026-42992-0 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|